In vitro metabolism of the neuropeptride antagonist, RWJ-58338, in rat and human hepatic S9 fractions.

被引：0
|
作者：
Wu, WN [1 ]
McKown, LA [1 ]
Kordik, CP [1 ]
Reitz, AB [1 ]
机构：
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
160
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [41] Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
    Zhu, Weixing
    Hu, Qingzhong
    Hanke, Nina
    van Koppen, Chris J.
    Hartmann, Rolf W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (18) : 7811 - 7817
  • [42] An in vitro reporter gene assay method incorporating metabolic activation with human and rat S9 or liver microsomes
    Sumida, K
    Ooe, N
    Nagahori, H
    Saito, K
    Isobe, N
    Kaneko, H
    Nakatsuka, I
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) : 85 - 91
  • [43] Hepatic Clearance of 6 Polycyclic Aromatic Hydrocarbons by Isolated Perfused Trout Livers: Prediction From In Vitro Clearance by Liver S9 Fractions
    Nichols, John W.
    Hoffman, Alex D.
    ter Laak, Thomas L.
    Fitzsimmons, Patrick N.
    TOXICOLOGICAL SCIENCES, 2013, 136 (02) : 359 - 372
  • [44] Comparative in vitro hepatic clearances of commonly used antidepressants, antipsychotics, and anti-inflammatory agents in rainbow trout liver S9 fractions
    Pihlaja, Tea L. M.
    Patsi, Jade
    Ollikainen, Elisa
    Sikanen, Tiina M.
    AQUATIC TOXICOLOGY, 2024, 274
  • [45] Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations
    Rudolph, Wiebke
    Remane, Daniela
    Wissenbach, Dirk K.
    Peters, Frank T.
    XENOBIOTICA, 2019, 49 (10) : 1149 - 1157
  • [46] In-vitro metabolism of isotetrandrine a, bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry
    Wu, WN
    McKown, LA
    Gopaul, VS
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (06) : 749 - 755
  • [47] Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS
    Gao, Yanhui
    Liu, Ruichen
    Gautam, Nagsen
    Ma, Bowen
    Xie, Zhiyu
    Sun, Bin
    Zheng, Hongbo
    Liu, Dongke
    Lou, Hongxiang
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 : 734 - 743
  • [48] Metabolic activation of 2-aminoanthracene and benz(a)pyrene to mutagens by rat hepatic S9 fraction and by hepatocytes induced in vivo or in vitro
    Jemnitz, K
    Veres, Z
    Torok, G
    Toth, E
    Vereczkey, L
    DRUG METABOLISM REVIEWS, 2003, 35 : 228 - 228
  • [49] Metabolism of alcohol ethoxylates (AEs) in rat, hamster, and human hepatocytes and liver S9: a pilot study for metabolic stability, metabolic pathway, and metabolites identification in vitro and in silico
    Shi, Quan
    Moors, Stefan
    Dawick, James
    Kavanagh, Lauren
    Neely, Theresa
    Tian, Yuan
    Dreessen, Birte
    Carrillo, Juan-Carlos
    Hein, Holger
    Boogaard, Peter J.
    ARCHIVES OF TOXICOLOGY, 2024, 98 (08) : 2487 - 2539
  • [50] The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment
    Cox, Julie A.
    Fellows, Mick D.
    Hashizume, Tsuneo
    White, Paul A.
    MUTAGENESIS, 2016, 31 (02) : 117 - 130
12345